Patient Reported Outcomes (PROs) and Investigator Global assessment (IGA) of Acne Vulgaris among patients with moderate to severe non-nodular Acne Vulgaris (AV) administered sarecycline in real-world community practices across the U.S. (PROSES Study)

Main Article Content

Emmy Graber
Hilary Baldwin
Julie C Harper
Linda Stein Gold
Ayman Grada
Andrew F Alexis
Adelaide A Hebert
Richard G Fried
Evan A Rieder
James Del Rosso
Siva Narayanan
Volker Koscielny
Ismail Kasujee
Leon Kircik

Keywords

acne, investigator global assessment, outcomes, sarecycline, PROSES

References

1. Bickers DR, Lim HW, Margolis D, et al. J Am Acad Dermatol. 2006; 55:490-500

2. Timms RM. Psychol Health Med. 2013; 18(3):310–320

3. Revol O, Milliez N, Gerard D. Br J Dermatol. 2015; 172(Suppl 1):52–58

4. Lasek RJ, Chren MM. Arch Dermatol. 1998; 134: 454-8

5. Gieler U et al. JEADV. 2015; 29 (Suppl. 4):12–14

6. Moore A, Green LJ, Bruce S, et al. J Drugs Dermatol. 2018 Sep 1;17(9):987-996

7. Hudgens S, Harper JC, Daniels SR, et al. J Drugs Dermatol. 2015; 14(6):552-9

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>